Yellow fever vaccine (live)

BIOLOGICAL3 trials

Sponsors

Sanofi, Sanofi Pasteur, a Sanofi Company

Conditions

Yellow FeverYellow Fever Immunization

Phase 3

Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults

CompletedNCT07002060

SanofiYellow Fever Immunization

Start: 2025-05-22End: 2026-01-20Updated: 2026-02-02

A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population

RecruitingNCT07103148

SanofiYellow Fever Immunization

Start: 2025-07-11End: 2030-03-04Target: 2440Updated: 2026-05-06

Phase 3 Single Arm, Open Study on vYF in Adults

CompletedNCT07222059

Sanofi Pasteur, a Sanofi CompanyYellow Fever

Start: 2025-10-23End: 2025-12-25Updated: 2026-02-03